Global Late Stage Chronic Kidney Disease Drugs Market Size, Status and Forecast 2023-2027

Report ID: 952939 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Late Stage Chronic Kidney Disease Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Calcimimetics
        1.2.3 Vitamin D Sterols
        1.2.4 Potassium Binders
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Late Stage Chronic Kidney Disease Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharnacies
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Late Stage Chronic Kidney Disease Drugs Market Perspective (2016-2027)
    2.2 Late Stage Chronic Kidney Disease Drugs Growth Trends by Regions
        2.2.1 Late Stage Chronic Kidney Disease Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Late Stage Chronic Kidney Disease Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Late Stage Chronic Kidney Disease Drugs Industry Dynamic
        2.3.1 Late Stage Chronic Kidney Disease Drugs Market Trends
        2.3.2 Late Stage Chronic Kidney Disease Drugs Market Drivers
        2.3.3 Late Stage Chronic Kidney Disease Drugs Market Challenges
        2.3.4 Late Stage Chronic Kidney Disease Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Late Stage Chronic Kidney Disease Drugs Players by Revenue
        3.1.1 Global Top Late Stage Chronic Kidney Disease Drugs Players by Revenue (2016-2021)
        3.1.2 Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Late Stage Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Late Stage Chronic Kidney Disease Drugs Revenue
    3.4 Global Late Stage Chronic Kidney Disease Drugs Market Concentration Ratio
        3.4.1 Global Late Stage Chronic Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Late Stage Chronic Kidney Disease Drugs Revenue in 2020
    3.5 Late Stage Chronic Kidney Disease Drugs Key Players Head office and Area Served
    3.6 Key Players Late Stage Chronic Kidney Disease Drugs Product Solution and Service
    3.7 Date of Enter into Late Stage Chronic Kidney Disease Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Late Stage Chronic Kidney Disease Drugs Breakdown Data by Type
    4.1 Global Late Stage Chronic Kidney Disease Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Type (2022-2027)

5 Late Stage Chronic Kidney Disease Drugs Breakdown Data by Application
    5.1 Global Late Stage Chronic Kidney Disease Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
    6.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type
        6.2.1 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
        6.2.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
        6.2.3 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
    6.3 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application
        6.3.1 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
        6.3.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
        6.3.3 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
    6.4 North America Late Stage Chronic Kidney Disease Drugs Market Size by Country
        6.4.1 North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
        6.4.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
    7.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type
        7.2.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
    7.3 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application
        7.3.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
    7.4 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country
        7.4.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type
        8.2.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application
        8.3.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region
        8.4.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
    9.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type
        9.2.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
    9.3 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application
        9.3.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
    9.4 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country
        9.4.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type
        10.2.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application
        10.3.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country
        10.4.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Late Stage Chronic Kidney Disease Drugs Introduction
        11.1.4 AbbVie Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.1.5 AbbVie Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Late Stage Chronic Kidney Disease Drugs Introduction
        11.2.4 Amgen Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.2.5 Amgen Recent Development
    11.3 Ardelyx
        11.3.1 Ardelyx Company Details
        11.3.2 Ardelyx Business Overview
        11.3.3 Ardelyx Late Stage Chronic Kidney Disease Drugs Introduction
        11.3.4 Ardelyx Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.3.5 Ardelyx Recent Development
    11.4 AstraZeneca
        11.4.1 AstraZeneca Company Details
        11.4.2 AstraZeneca Business Overview
        11.4.3 AstraZeneca Late Stage Chronic Kidney Disease Drugs Introduction
        11.4.4 AstraZeneca Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.4.5 AstraZeneca Recent Development
    11.5 Deltanoid
        11.5.1 Deltanoid Company Details
        11.5.2 Deltanoid Business Overview
        11.5.3 Deltanoid Late Stage Chronic Kidney Disease Drugs Introduction
        11.5.4 Deltanoid Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.5.5 Deltanoid Recent Development
    11.6 Akebia Therapeutics
        11.6.1 Akebia Therapeutics Company Details
        11.6.2 Akebia Therapeutics Business Overview
        11.6.3 Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Introduction
        11.6.4 Akebia Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.6.5 Akebia Therapeutics Recent Development
    11.7 Kyowa Hakko Kirin
        11.7.1 Kyowa Hakko Kirin Company Details
        11.7.2 Kyowa Hakko Kirin Business Overview
        11.7.3 Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Introduction
        11.7.4 Kyowa Hakko Kirin Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.7.5 Kyowa Hakko Kirin Recent Development
    11.8 OPKO Health
        11.8.1 OPKO Health Company Details
        11.8.2 OPKO Health Business Overview
        11.8.3 OPKO Health Late Stage Chronic Kidney Disease Drugs Introduction
        11.8.4 OPKO Health Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.8.5 OPKO Health Recent Development
    11.9 Vifor Pharma
        11.9.1 Vifor Pharma Company Details
        11.9.2 Vifor Pharma Business Overview
        11.9.3 Vifor Pharma Late Stage Chronic Kidney Disease Drugs Introduction
        11.9.4 Vifor Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.9.5 Vifor Pharma Recent Development
    11.10 Sanofi
        11.10.1 Sanofi Company Details
        11.10.2 Sanofi Business Overview
        11.10.3 Sanofi Late Stage Chronic Kidney Disease Drugs Introduction
        11.10.4 Sanofi Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.10.5 Sanofi Recent Development
    11.11 Shield Therapeutics
        11.11.1 Shield Therapeutics Company Details
        11.11.2 Shield Therapeutics Business Overview
        11.11.3 Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Introduction
        11.11.4 Shield Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.11.5 Shield Therapeutics Recent Development
    11.12 Shire
        11.12.1 Shire Company Details
        11.12.2 Shire Business Overview
        11.12.3 Shire Late Stage Chronic Kidney Disease Drugs Introduction
        11.12.4 Shire Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.12.5 Shire Recent Development
    11.13 Spectrum
        11.13.1 Spectrum Company Details
        11.13.2 Spectrum Business Overview
        11.13.3 Spectrum Late Stage Chronic Kidney Disease Drugs Introduction
        11.13.4 Spectrum Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.13.5 Spectrum Recent Development
    11.14 ZS Pharma
        11.14.1 ZS Pharma Company Details
        11.14.2 ZS Pharma Business Overview
        11.14.3 ZS Pharma Late Stage Chronic Kidney Disease Drugs Introduction
        11.14.4 ZS Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
        11.14.5 ZS Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Late Stage Chronic Kidney Disease Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Calcimimetics
    Table 3. Key Players of Vitamin D Sterols
    Table 4. Key Players of Potassium Binders
    Table 5. Key Players of Others
    Table 6. Global Late Stage Chronic Kidney Disease Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Late Stage Chronic Kidney Disease Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Late Stage Chronic Kidney Disease Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions (2016-2021)
    Table 10. Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions (2022-2027)
    Table 12. Late Stage Chronic Kidney Disease Drugs Market Trends
    Table 13. Late Stage Chronic Kidney Disease Drugs Market Drivers
    Table 14. Late Stage Chronic Kidney Disease Drugs Market Challenges
    Table 15. Late Stage Chronic Kidney Disease Drugs Market Restraints
    Table 16. Global Late Stage Chronic Kidney Disease Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Late Stage Chronic Kidney Disease Drugs Market Share by Players (2016-2021)
    Table 18. Global Top Late Stage Chronic Kidney Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Late Stage Chronic Kidney Disease Drugs as of 2020)
    Table 19. Ranking of Global Top Late Stage Chronic Kidney Disease Drugs Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Late Stage Chronic Kidney Disease Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Late Stage Chronic Kidney Disease Drugs Product Solution and Service
    Table 23. Date of Enter into Late Stage Chronic Kidney Disease Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
    Table 27. Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Late Stage Chronic Kidney Disease Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Application (2016-2021)
    Table 31. Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Late Stage Chronic Kidney Disease Drugs Product
    Table 66. AbbVie Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 67. AbbVie Recent Development
    Table 68. Amgen Company Details
    Table 69. Amgen Business Overview
    Table 70. Amgen Late Stage Chronic Kidney Disease Drugs Product
    Table 71. Amgen Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 72. Amgen Recent Development
    Table 73. Ardelyx Company Details
    Table 74. Ardelyx Business Overview
    Table 75. Ardelyx Late Stage Chronic Kidney Disease Drugs Product
    Table 76. Ardelyx Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 77. Ardelyx Recent Development
    Table 78. AstraZeneca Company Details
    Table 79. AstraZeneca Business Overview
    Table 80. AstraZeneca Late Stage Chronic Kidney Disease Drugs Product
    Table 81. AstraZeneca Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 82. AstraZeneca Recent Development
    Table 83. Deltanoid Company Details
    Table 84. Deltanoid Business Overview
    Table 85. Deltanoid Late Stage Chronic Kidney Disease Drugs Product
    Table 86. Deltanoid Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 87. Deltanoid Recent Development
    Table 88. Akebia Therapeutics Company Details
    Table 89. Akebia Therapeutics Business Overview
    Table 90. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Product
    Table 91. Akebia Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 92. Akebia Therapeutics Recent Development
    Table 93. Kyowa Hakko Kirin Company Details
    Table 94. Kyowa Hakko Kirin Business Overview
    Table 95. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Product
    Table 96. Kyowa Hakko Kirin Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 97. Kyowa Hakko Kirin Recent Development
    Table 98. OPKO Health Company Details
    Table 99. OPKO Health Business Overview
    Table 100. OPKO Health Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 101. OPKO Health Recent Development
    Table 102. Vifor Pharma Company Details
    Table 103. Vifor Pharma Business Overview
    Table 104. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Product
    Table 105. Vifor Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 106. Vifor Pharma Recent Development
    Table 107. Sanofi Company Details
    Table 108. Sanofi Business Overview
    Table 109. Sanofi Late Stage Chronic Kidney Disease Drugs Product
    Table 110. Sanofi Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 111. Sanofi Recent Development
    Table 112. Shield Therapeutics Company Details
    Table 113. Shield Therapeutics Business Overview
    Table 114. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Product
    Table 115. Shield Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 116. Shield Therapeutics Recent Development
    Table 117. Shire Company Details
    Table 118. Shire Business Overview
    Table 119. Shire Late Stage Chronic Kidney Disease Drugs Product
    Table 120. Shire Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 121. Shire Recent Development
    Table 122. Spectrum Company Details
    Table 123. Spectrum Business Overview
    Table 124. Spectrum Late Stage Chronic Kidney Disease Drugs Product
    Table 125. Spectrum Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 126. Spectrum Recent Development
    Table 127. ZS Pharma Company Details
    Table 128. ZS Pharma Business Overview
    Table 129. ZS Pharma Late Stage Chronic Kidney Disease Drugs Product
    Table 130. ZS Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
    Table 131. ZS Pharma Recent Development
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Late Stage Chronic Kidney Disease Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Calcimimetics Features
    Figure 3. Vitamin D Sterols Features
    Figure 4. Potassium Binders Features
    Figure 5. Others Features
    Figure 6. Global Late Stage Chronic Kidney Disease Drugs Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Online Pharnacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Late Stage Chronic Kidney Disease Drugs Report Years Considered
    Figure 11. Global Late Stage Chronic Kidney Disease Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Late Stage Chronic Kidney Disease Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions: 2020 VS 2027
    Figure 14. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions (2022-2027)
    Figure 15. Global Late Stage Chronic Kidney Disease Drugs Market Share by Players in 2020
    Figure 16. Global Top Late Stage Chronic Kidney Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Late Stage Chronic Kidney Disease Drugs as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Late Stage Chronic Kidney Disease Drugs Revenue in 2020
    Figure 18. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
    Figure 19. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2022-2027)
    Figure 20. North America Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
    Figure 22. North America Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
    Figure 23. North America Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
    Figure 24. United States Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
    Figure 28. Europe Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
    Figure 29. Europe Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
    Figure 30. Germany Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Share by Region (2016-2027)
    Figure 40. China Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
    Figure 48. Latin America Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
    Figure 49. Latin America Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
    Figure 50. Mexico Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
    Figure 56. Turkey Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. AbbVie Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 60. Amgen Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 61. Ardelyx Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 62. AstraZeneca Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 63. Deltanoid Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 64. Akebia Therapeutics Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 65. Kyowa Hakko Kirin Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 66. OPKO Health Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 67. Vifor Pharma Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 68. Sanofi Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 69. Shield Therapeutics Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 70. Shire Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 71. Spectrum Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 72. ZS Pharma Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Amgen
Ardelyx
AstraZeneca
Deltanoid
Akebia Therapeutics
Kyowa Hakko Kirin
OPKO Health
Vifor Pharma
Sanofi
Shield Therapeutics
Shire
Spectrum
ZS Pharma
Frequently Asked Questions
Late Stage Chronic Kidney Disease Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Late Stage Chronic Kidney Disease Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Late Stage Chronic Kidney Disease Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports